While Attention Is on a Pfizer (PFE) Dividend Raise, Merck (MRK) Could Be Ripe for a Hike Too - Analyst

Go back to While Attention Is on a Pfizer (PFE) Dividend Raise, Merck (MRK) Could Be Ripe for a Hike Too - Analyst
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1255.40 +11.00 (0.88%)
Previous Close $1244.40    52 Week High $88.16 
Open $1232.00    52 Week Low $67.88 
Day High $1271.22    P/E 290.60 
Day Low $1230.00    EPS $4.32 
Volume 2,505,585       

Merck & Co. (NYSE: MRK) Delayed: 152.55 +3.56 (2.39%)
Previous Close $148.99    52 Week High $65.46 
Open $149.12    52 Week Low $47.97 
Day High $154.49    P/E 103.78 
Day Low $148.59    EPS $1.47 
Volume 15,974,897       

Pfizer Inc. (NYSE: PFE) Delayed: 28.07 +0.28 (1.01%)
Previous Close $27.79    52 Week High $37.39 
Open $27.77    52 Week Low $28.25 
Day High $28.43    P/E 17.01 
Day Low $27.66    EPS $1.65 
Volume 37,094,598